Euro Q4 Earnings Preview: GSK, Sanofi, Bayer And Reckitt
Executive Summary
Major Europe-based consumer health players GSK, Sanofi, Bayer and Reckitt feature in this earnings preview, which highlights what to look out for as these four firms report their Q4 and annual results over the coming weeks.
You may also be interested in...
Euro Q3 Consumer Health Earnings Preview: Helm Changes, Investor Questions, Results Debut
Major Europe-based consumer health players Reckitt, Bayer, Sanofi and Haleon feature in this sales and earnings preview, which highlights what to look out for as these four firms report their Q3 2022 results over the coming weeks.
P&G's Feminine Care Sales Up As Incontinence, Menstrual Products Get Superiority Attention
Procter & Gamble CEO Jon Moeller and and feminine products chief Jennifer Davis outline firm's strategies and focus areas in sustainability and superiority in 2022. While more than half consumers are interested in natural or more sustainable products, few will settle for lesser product performance, Davis said. But they appear willing to pay a premium for products made with sustainable materials.
Sanofi Pairs Up With Non-Profit Protas In Quest To Cut Clinical Trial Costs
The French major has committed up to £5m for non-profit Protas, which aims to facilitate large clinical studies at a fraction of the usual price and form more pharmaceutical collaborations down the line.